1068 related articles for article (PubMed ID: 15352070)
21. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
Nash KL; Alexander GJ; Lever AM
J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
[TBL] [Abstract][Full Text] [Related]
22. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
23. Targeted transgene expression in rat brain using lentiviral vectors.
Jakobsson J; Ericson C; Jansson M; Björk E; Lundberg C
J Neurosci Res; 2003 Sep; 73(6):876-85. PubMed ID: 12949915
[TBL] [Abstract][Full Text] [Related]
24. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo.
Zhao J; Pettigrew GJ; Thomas J; Vandenberg JI; Delriviere L; Bolton EM; Carmichael A; Martin JL; Marber MS; Lever AM
Basic Res Cardiol; 2002 Sep; 97(5):348-58. PubMed ID: 12200634
[TBL] [Abstract][Full Text] [Related]
25. Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo.
Fleury S; Simeoni E; Zuppinger C; Déglon N; von Segesser LK; Kappenberger L; Vassalli G
Circulation; 2003 May; 107(18):2375-82. PubMed ID: 12695294
[TBL] [Abstract][Full Text] [Related]
26. Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
Ikeda Y; Collins MK; Radcliffe PA; Mitrophanous KA; Takeuchi Y
Gene Ther; 2002 Jul; 9(14):932-8. PubMed ID: 12085241
[TBL] [Abstract][Full Text] [Related]
27. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors.
Arad U; Axelrod J; Ben-nun-Shaul O; Oppenheim A; Galun E
J Hepatol; 2004 Mar; 40(3):520-6. PubMed ID: 15123369
[TBL] [Abstract][Full Text] [Related]
29. Efficient ex vivo gene transfer into non-human primate hepatocytes using HIV-1 derived lentiviral vectors.
Parouchev A; Nguyen TH; Dagher I; Mainot S; Groyer-Picard MT; Branger J; Gonin P; Di Santo J; Franco D; Gras G; Weber A
J Hepatol; 2006 Jul; 45(1):99-107. PubMed ID: 16723167
[TBL] [Abstract][Full Text] [Related]
30. Purkinje-cell-preferential transduction by lentiviral vectors with the murine stem cell virus promoter.
Takayama K; Torashima T; Horiuchi H; Hirai H
Neurosci Lett; 2008 Sep; 443(1):7-11. PubMed ID: 18675313
[TBL] [Abstract][Full Text] [Related]
31. Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.
Chapel-Fernandes S; Jordier F; Lauro F; Maitland N; Chiaroni J; de Micco P; Mannoni P; Bagnis C
Cancer Gene Ther; 2006 Oct; 13(10):919-29. PubMed ID: 16741521
[TBL] [Abstract][Full Text] [Related]
32. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.
Kafri T; Blömer U; Peterson DA; Gage FH; Verma IM
Nat Genet; 1997 Nov; 17(3):314-7. PubMed ID: 9354796
[TBL] [Abstract][Full Text] [Related]
33. HIV-1-derived lentiviral vectors and fetal route of administration on transgene biodistribution and expression in rhesus monkeys.
Jimenez DF; Lee CI; O'Shea CE; Kohn DB; Tarantal AF
Gene Ther; 2005 May; 12(10):821-30. PubMed ID: 15815706
[TBL] [Abstract][Full Text] [Related]
34. Lentivirus vector driven by polybiquitin C promoter without woodchuck posttranscriptional regulatory element and central polypurine tract generates low level and short-lived reporter gene expression.
Ngai SC; Rosli R; Nordin N; Veerakumarasivam A; Abdullah S
Gene; 2012 May; 498(2):231-6. PubMed ID: 22366305
[TBL] [Abstract][Full Text] [Related]
35. [Construction and expression of EGFP controlled HBV promoters in eukaryotic cells].
Xie N; Wang XY; Zhang Q; Lin YY; Lin JS
Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):268-71. PubMed ID: 16635295
[TBL] [Abstract][Full Text] [Related]
36. Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct.
Curtin JA; Dane AP; Swanson A; Alexander IE; Ginn SL
Gene Ther; 2008 Mar; 15(5):384-90. PubMed ID: 18283290
[TBL] [Abstract][Full Text] [Related]
37. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
[TBL] [Abstract][Full Text] [Related]
38. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
[TBL] [Abstract][Full Text] [Related]
39. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.
Guo ZS; Wang LH; Eisensmith RC; Woo SL
Gene Ther; 1996 Sep; 3(9):802-10. PubMed ID: 8875229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
